Castle Biosciences Inc (CSTL.O)

+ 收藏

资产负债表(Castle Biosciences Inc)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2025年年报2025年三季报2025年中报2025年一季报2024年年报2024年三季报2024年中报2024年一季报
截止日期 2025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-302024-03-31
报表类型 合并报表合并报表合并报表合并报表合并报表合并报表合并报表合并报表
报表年结日 12311231123112311231123112311231
原始币种 美元美元美元美元美元美元美元美元
上市前/上市后 上市后上市后上市后上市后上市后上市后上市后上市后
流动资产:
 现金及现金等价物(元) 会员可见会员可见会员可见会员可见119,709,000.0094,959,000.0085,572,000.0082,949,000.00
 应收账款及票据(元) 会员可见会员可见会员可见会员可见51,218,000.0050,261,000.0045,988,000.0042,699,000.00
 预付款项及其他应收款流动(元) 会员可见会员可见会员可见会员可见7,671,000.008,154,000.006,716,000.006,221,000.00
 存货(元) 会员可见会员可见会员可见会员可见8,135,000.006,572,000.008,013,000.007,645,000.00
 短期投资(元) 会员可见会员可见会员可见会员可见173,421,000.00184,826,000.00174,116,000.00156,264,000.00
 流动资产合计(元) 会员可见会员可见会员可见会员可见360,154,000.00344,772,000.00320,405,000.00295,778,000.00
非流动资产:
 物业、厂房及设备(元) 会员可见会员可见会员可见会员可见51,122,000.0044,383,000.0038,638,000.0032,904,000.00
 商誉(元) 会员可见会员可见会员可见会员可见106,229,000.00110,569,000.00112,840,000.00115,088,000.00
 预付款项及其他长期应收款非流动(元) 会员可见会员可见会员可见会员可见918,000.001,106,000.001,125,000.001,056,000.00
 长期投资(元) ---会员可见----
 非流动资产其他项目(元) 会员可见会员可见会员可见会员可见12,812,000.0013,735,000.0014,304,000.0013,681,000.00
 非流动资产合计(元) 会员可见会员可见会员可见会员可见171,081,000.00169,793,000.00166,907,000.00162,729,000.00
总资产(元) 会员可见会员可见会员可见会员可见531,235,000.00514,565,000.00487,312,000.00458,507,000.00
流动负债:
 短期债务及长期负债本期部分(元) 会员可见-会员可见会员可见278,000.00---
 融资租赁负债流动(元) 会员可见会员可见会员可见会员可见1,665,000.001,745,000.001,226,000.001,189,000.00
 应付账款及票据(元) 会员可见会员可见会员可见会员可见6,901,000.006,810,000.009,540,000.009,318,000.00
 应付薪酬和福利(元) 会员可见会员可见会员可见会员可见32,555,000.0027,672,000.0021,239,000.0014,708,000.00
 其他应付款及应计费用(元) 会员可见会员可见会员可见会员可见7,993,000.008,068,000.007,449,000.006,744,000.00
 流动负债其他项目(元) 会员可见会员可见会员可见-----
 流动负债合计(元) 会员可见会员可见会员可见会员可见49,392,000.0044,295,000.0039,454,000.0031,959,000.00
非流动负债:
 长期债务(元) 会员可见会员可见会员可见会员可见9,745,000.0010,015,000.0010,008,000.0010,000,000.00
 融资租赁负债非流动(元) 会员可见会员可见会员可见会员可见14,656,000.0014,980,000.0013,957,000.0013,864,000.00
 递延所得税负债非流动(元) 会员可见会员可见会员可见会员可见1,607,000.004,220,000.00-206,000.00
 非流动负债其他项目(元) 会员可见会员可见会员可见----16,000.00
 非流动负债合计(元) 会员可见会员可见会员可见会员可见26,008,000.0029,215,000.0023,965,000.0024,086,000.00
总负债(元) 会员可见会员可见会员可见会员可见75,400,000.0073,510,000.0063,419,000.0056,045,000.00
股东权益:
 普通股(元) 会员可见会员可见会员可见会员可见28,000.0028,000.0028,000.0028,000.00
 股本溢价(元) 会员可见会员可见会员可见会员可见655,703,000.00650,270,000.00636,022,000.00623,450,000.00
 留存收益(元) 会员可见会员可见会员可见会员可见-200,126,000.00-209,716,000.00-211,985,000.00-220,905,000.00
 累计其他全面收益(元) 会员可见会员可见会员可见会员可见230,000.00473,000.00-172,000.00-111,000.00
 归属于母公司股东权益(元) 会员可见会员可见会员可见会员可见455,835,000.00441,055,000.00423,893,000.00402,462,000.00
 股东权益合计(元) 会员可见会员可见会员可见会员可见455,835,000.00441,055,000.00423,893,000.00402,462,000.00
负债及股东权益合计(元) 会员可见会员可见会员可见会员可见531,235,000.00514,565,000.00487,312,000.00458,507,000.00
公告日期 2026-02-262025-11-032025-08-042025-05-052025-02-272024-11-042024-08-052024-05-02
会计准则 美国会计准则美国会计准则美国会计准则美国会计准则美国会计准则美国会计准则美国会计准则美国会计准则
审计意见
核数师

前瞻产业研究院